Last updated on December 2018

Modulation of Anti-tumor T Cell Responses in Cancer Patients Treated by Concomitant Radiochemotherapy


Brief description of study

The aim of this study is to evaluate modulation of anti-tumor T cell responses in cancer patients treated by concomitant radiochemotherapy (i-RTCT)

Clinical Study Identifier: NCT03117946

Find a site near you

Start Over